Search form
Search
contact us
Navigation
home
boards
job center
job ratings
cp wire
device news
trending now
trending in pharma/biotech
trending in device
pharmagather
advertise
Legal Help
login/register
You are here
Home
» Lilly revs up to challenge Pfizer, Novartis in breast cancer with abemaciclib 'priority' nod
Lilly revs up to challenge Pfizer, Novartis in breast cancer with abemaciclib 'priority' nod
Lilly revs up to challenge Pfizer, Novartis in breast cancer with abemaciclib 'priority' nod
Submitted by
admin
on July 11, 2017 - 9:56am
Source:
Fierce Pharma
News Tags:
Eli Lilly
Pfizer
Novartis
breast cancer
abemaciclib
Ibrance
Kisqali
Headline:
Lilly revs up to challenge Pfizer, Novartis in breast cancer with abemaciclib 'priority' nod
